SCHEMBL5287500

SCHEMBL5287500

O=C(CBr)CCCCCNC(=O)COCc1ccc(F)cc1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.43
HDAC1 Q13547 4/20 0.42
HDAC3 O15379 3/20 0.42
HDAC2 Q92769 3/20 0.42
HDAC8 Q9BY41 3/20 0.42
LMNA P02545 3/20 0.41
KMT2A Q03164 1/20 0.40
HDAC6 Q9UBN7 4/20 0.40
HDAC4 P56524 2/20 0.40
HDAC7 Q8WUI4 2/20 0.40
HDAC10 Q969S8 2/20 0.40
HDAC11 Q96DB2 2/20 0.40
HDAC9 Q9UKV0 2/20 0.40
HDAC5 Q9UQL6 2/20 0.40
HPGD P15428 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
EPHX2 P34913 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5282279 0.86 ITGB3 (0.47) RAB9AHDAC1HDAC3HDAC2HDAC8
SCHEMBL5278715 0.85 RAB9A (0.45) RAB9AHDAC1HDAC3HDAC2HDAC8
SCHEMBL5286752 0.82 RAB9A (0.47) RAB9AHDAC1HDAC3HDAC2HDAC8
SCHEMBL5287408 0.82 RAB9A (0.47) RAB9AHDAC1HDAC3HDAC2HDAC8
SCHEMBL5280483 0.81 RAB9A (0.48) RAB9ALMNAKMT2AHPGDALDH1A1
SCHEMBL6037902 0.80 RAB9A (0.50) RAB9ALMNAKMT2AHPGDALDH1A1
SCHEMBL5287584 0.80 RAB9A (0.45) RAB9AHDAC1HDAC3HDAC2HDAC8
SCHEMBL5278754 0.80 RAB9A (0.45) RAB9AHDAC1HDAC3HDAC2HDAC8
SCHEMBL20378796 0.79 RAB9A (0.39) RAB9AHDAC1HDAC3HDAC2HDAC8
SCHEMBL5287591 0.78 RAB9A (0.41) RAB9AHDAC1HDAC3HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1863804-A1 INHIBITORS OF HISTONE DEACETYLASE Methylgene, Inc. (CA) 2007-12-12 EP disclosed
US-20060264415-A1 Inhibitors of histone deacetylase METHYLGENE INC. 2006-11-23 US disclosed
WO-2006102760-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2006-10-05 WO disclosed
WO-2006102760-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2006-10-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264415-A1 Inhibitors of histone deacetylase HDAC1, HDAC3, HDAC11 RAB9A 2884/4885HDAC1 1/4885HDAC3 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.